Miracalus Pharma

Mumbai, India Founded: 2006 • Age: 20 yrs
Manufacturer of branded generics for cancer

About Miracalus Pharma

Miracalus Pharma is a company based in Mumbai (India) founded in 2006 by Mohan Jain and Babulal Keshrimal Jain. It operates as a Traditional Pharmaceuticals. The company has 21 employees. Miracalus Pharma offers products and services including Miracalus Pharma Platform.

  • Headquarter Mumbai, India
  • Employees 21
  • Founders Mohan Jain, Babulal Keshrimal Jain
  • Sectors
    Healthcare
  • Website miracalus.com
  • Legal Name Miracalus Pharma Private Limited
  • Date of Incorporation 22 May, 2007
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹12.12 Cr

    FY 2025 · -18% YoY

  • Net Profit
    ₹51.8 Lakh

    FY 2025 · 4% margin

  • EBITDA
    ₹61.7 Lakh

    FY 2025 · 5% margin

  • Employee Count
    21

Products & Services of Miracalus Pharma

Miracalus Pharma offers a comprehensive portfolio of products and services, including Miracalus Pharma Platform.

Miracalus Pharma Platform
Healthcare

Manufacturer of branded generics for cancer

Board of directors of Miracalus Pharma Private Limited (Miracalus Pharma)

Miracalus Pharma Private Limited is the primary company behind Miracalus Pharma. The board of Miracalus Pharma Private Limited currently have 3 directors; the longest-serving is Mohan Babulal Jain, appointed in 2007. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mohan Babulal Jain
DIN 00054461
Director22 May 200719 yrs 4 moMiracalus Pharma Private Limited
Manish Babulal Jain
DIN 01538004
Director11 Sep 20188 yrsMiracalus Pharma Private Limited
Aarya Mohan Jain
DIN 11000730
Director13 Mar 20251 yr 6 moMiracalus Pharma Private Limited

People of Miracalus Pharma

2 people are tracked at Miracalus Pharma (2 in leadership); the tracked headcount is 21.

NameRoleGroup
Co-Founder & DirectorLeadership
Co-Founder & DirectorLeadership
Premium access

Complete people profiles for Miracalus Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Miracalus Pharma

Figures of Miracalus Pharma Private Limited, the primary company behind Miracalus Pharma, for FY 2025. Revenue was ₹12.12 Cr (-18% year on year). Net profit was ₹51.8 Lakh (4% margin). EBITDA was ₹61.7 Lakh (5% margin). Revenue has grown at a compounded annual rate of -19% over three years and -11% over five years.

  • ₹12.12 CrRevenue · FY 2025 · -18% YoY
  • ₹51.8 LakhNet profit · 4% margin
  • ₹61.7 LakhEBITDA · 5% margin
  • ₹1.7 LakhPaid-up capital
  • 21Employees (provident fund records)
  • -19%Revenue CAGR, 3 years
  • -11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Miracalus Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Miracalus Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Miracalus Pharma

10 companies that operate in the same segment as Miracalus Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Miracalus Pharma

Miracalus Pharma was founded in 2006.

Miracalus Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Miracalus Pharma has 21 employees.

The primary company behind Miracalus Pharma, Miracalus Pharma Private Limited, reported revenue of β‚Ή12.12 Cr for FY 2025, down 18% year on year.

Miracalus Pharma, founded in 2006 in Mumbai, India, focuses on oncology, companies, traditional pharmaceuticals, and companies developing and commercializing generics focused on oncology. Manufacturer of branded generics for cancer. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Miracalus Pharma offers Miracalus Pharma Platform.

Miracalus Pharma operates through Miracalus Pharma Private Limited.

The legal entities of Miracalus Pharma currently have 3 directors, including Manish Babulal Jain, Mohan Babulal Jain, Aarya Mohan Jain.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available